ArticleCureus2026
Dapagliflozin-Induced Dermatological Condition: Sweet's Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sweet's syndrome, or acute febrile neutrophilic dermatosis, is an uncommon inflammatory condition characterized by the sudden onset of fever, neutrophilia, and painful erythematous skin lesions. We present the case of a 54-year-old female who was started on anti-glycemic medication for glycemic control and developed tender erythematous plaques and nodules over the upper limbs. Comprehensive evaluation excluded infectious, autoimmune, endocrine, and neoplastic causes. Skin biopsy demonstrated a dense neutrophilic infiltrate without evidence of vasculitis, supporting the diagnosis of Sweet's syndrome. The patient was managed with systemic corticosteroids, resulting in clinical improvement. This case emphasizes the importance of recognizing Sweet's syndrome in the context of drug-induced etiology, as well as the role of timely dermatologic assessment and metabolic stabilization in achieving favorable outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.